Skip to content

Clinical trials

Completed Observational Graft vs Host Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Phase: Observational Status: Completed Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20051
20062
20073
20082
20091
20103
20113
20121
20133
20144
20153
20172
20185
20191
20212
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ann & Robert H Lurie Children's Hospital of Chicago3
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia2
IRCCS Azienda Ospedaliero-Universitaria di Bologna2
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
National Institute of Dental and Craniofacial Research (NIDCR)2
University of Freiburg2
University of Pisa2
Vanderbilt University2
Affiliated Hospital to Academy of Military Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease44
Hematologic Neoplasms5
Bronchiolitis Obliterans Syndrome4
Autoimmune Diseases3
Myelodysplastic Syndromes3
Leukemia, Myeloid, Acute2
Lymphoma2
Myelodysplastic-Myeloproliferative Diseases2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Scleroderma, Localized2

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.